APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Repurposing Platform

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI Drug Repurposing Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026199 pages

Choose your research edition.

Industry ResearchAI Drug Repurposing Platform Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Repurposing Platform Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal AI Drug Repurposing Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Repurposing Platform Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Repurposing Platform Market Analysis and Forecast 2026-2032178 pages · $4,950 USD

Market perspective

The global AI Drug Repurposing Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI Drug Repurposing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Drug Repurposing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Repurposing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI Drug Repurposing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI Drug Repurposing Platform include Recursion, Lantern Pharma, SOM Biotech, Standigm, Pharos iBio, Aitia, Causaly, BenevolentAI and Healx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI Drug Repurposing Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Drug Repurposing Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Drug Repurposing Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Drug Repurposing Platform market size, projected growth trends, production technologies, key applications, and end-use industries.

AI Drug Repurposing Platform Segment by Company

Recursion

Lantern Pharma

SOM Biotech

Standigm

Pharos iBio

Aitia

Causaly

BenevolentAI

Healx

Insilico Medicine

AI Drug Repurposing Platform Segment by Type

Target and Mechanism Mining

Drug–Disease Matching

Indication Expansion

Combination Therapy Prediction

Evidence Ranking and Validation

Safety and Translational Assessment

AI Drug Repurposing Platform Segment by Application

Rare Disease Repurposing

Oncology Indication Expansion

Infectious Disease Response

CNS and Neurology Research

Immunology and Inflammation Research

Asset Rescue and Pipeline Optimization

AI Drug Repurposing Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Repurposing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Repurposing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Repurposing Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Drug Repurposing Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Repurposing Platform industry.

Chapter 3: Detailed analysis of AI Drug Repurposing Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Repurposing Platformrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Repurposing Platform Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Target and Mechanism Mining Table 3. Key Players of Drug–Disease Matching Table 4. Key Players of Indication Expansion Table 3. Key Players of Combination Therapy Prediction Table 4. Key Players of Evidence Ranking and Validation Table 5. Key Players of Safety and Translational Assessment Table 6. Global AI Drug Repurposing Platform Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Rare Disease Repurposing Table 8. Key Players of Oncology Indication Expansion Table 9. Key Players of Infectious Disease Response Table 10. Key Players of CNS and Neurology Research Table 11. Key Players of Immunology and Inflammation Research Table 12. Key Players of Asset Rescue and Pipeline Optimization Table 13. Global AI Drug Repurposing Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI Drug Repurposing Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI Drug Repurposing Platform Market Share by Region (2021-2026) Table 16. Global AI Drug Repurposing Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI Drug Repurposing Platform Market Share by Region (2027-2032) Table 18. AI Drug Repurposing Platform Industry Trends Table 19. AI Drug Repurposing Platform Industry Drivers Table 20. AI Drug Repurposing Platform Industry Opportunities and Challenges Table 21. AI Drug Repurposing Platform Industry Restraints Table 22. Global AI Drug Repurposing Platform Revenue by Company (US$ Million) & (2021-2026) Table 23. Global AI Drug Repurposing Platform Revenue Market Share by Company (2021-2026) Table 24. Global AI Drug Repurposing Platform Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global AI Drug Repurposing Platform Key Company Head Office and Area Served Table 26. Global AI Drug Repurposing Platform Company, Product Type & Application Table 27. Global AI Drug Repurposing Platform Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global AI Drug Repurposing Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global AI Drug Repurposing Platform Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Drug Repurposing Platform Market Size by Type (2021-2026) & (US$ Million) Table 32. Global AI Drug Repurposing Platform Market Size by Type (2027-2032) & (US$ Million) Table 33. Global AI Drug Repurposing Platform Revenue Market Share by Type (2021-2026) Table 34. Global AI Drug Repurposing Platform Revenue Market Share by Type (2027-2032) Table 35. Global AI Drug Repurposing Platform Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Drug Repurposing Platform Market Size by Application (2021-2026) & (US$ Million) Table 37. Global AI Drug Repurposing Platform Market Size by Application (2027-2032) & (US$ Million) Table 38. Global AI Drug Repurposing Platform Revenue Market Share by Application (2021-2026) Table 39. Global AI Drug Repurposing Platform Revenue Market Share by Application (2027-2032) Table 40. Recursion Company Information Table 41. Recursion Business Overview Table 42. Recursion AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Recursion AI Drug Repurposing Platform Product Portfolio Table 44. Recursion Recent Development Table 45. Lantern Pharma Company Information Table 46. Lantern Pharma Business Overview Table 47. Lantern Pharma AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Lantern Pharma AI Drug Repurposing Platform Product Portfolio Table 49. Lantern Pharma Recent Development Table 50. SOM Biotech Company Information Table 51. SOM Biotech Business Overview Table 52. SOM Biotech AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. SOM Biotech AI Drug Repurposing Platform Product Portfolio Table 54. SOM Biotech Recent Development Table 55. Standigm Company Information Table 56. Standigm Business Overview Table 57. Standigm AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Standigm AI Drug Repurposing Platform Product Portfolio Table 59. Standigm Recent Development Table 60. Pharos iBio Company Information Table 61. Pharos iBio Business Overview Table 62. Pharos iBio AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pharos iBio AI Drug Repurposing Platform Product Portfolio Table 64. Pharos iBio Recent Development Table 65. Aitia Company Information Table 66. Aitia Business Overview Table 67. Aitia AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Aitia AI Drug Repurposing Platform Product Portfolio Table 69. Aitia Recent Development Table 70. Causaly Company Information Table 71. Causaly Business Overview Table 72. Causaly AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Causaly AI Drug Repurposing Platform Product Portfolio Table 74. Causaly Recent Development Table 75. BenevolentAI Company Information Table 76. BenevolentAI Business Overview Table 77. BenevolentAI AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BenevolentAI AI Drug Repurposing Platform Product Portfolio Table 79. BenevolentAI Recent Development Table 80. Healx Company Information Table 81. Healx Business Overview Table 82. Healx AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Healx AI Drug Repurposing Platform Product Portfolio Table 84. Healx Recent Development Table 85. Insilico Medicine Company Information Table 86. Insilico Medicine Business Overview Table 87. Insilico Medicine AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Insilico Medicine AI Drug Repurposing Platform Product Portfolio Table 89. Insilico Medicine Recent Development Table 90. North America AI Drug Repurposing Platform Market Size by Type (2021-2026) & (US$ Million) Table 91. North America AI Drug Repurposing Platform Market Size by Type (2027-2032) & (US$ Million) Table 92. North America AI Drug Repurposing Platform Market Size by Application (2021-2026) & (US$ Million) Table 93. North America AI Drug Repurposing Platform Market Size by Application (2027-2032) & (US$ Million) Table 94. North America AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America AI Drug Repurposing Platform Market Size by Country (2021-2026) Table 96. North America AI Drug Repurposing Platform Market Size by Country (2027-2032) Table 97. Europe AI Drug Repurposing Platform Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe AI Drug Repurposing Platform Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe AI Drug Repurposing Platform Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe AI Drug Repurposing Platform Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe AI Drug Repurposing Platform Market Size by Country (2021-2026) Table 103. Europe AI Drug Repurposing Platform Market Size by Country (2027-2032) Table 104. China AI Drug Repurposing Platform Market Size by Type (2021-2026) & (US$ Million) Table 105. China AI Drug Repurposing Platform Market Size by Type (2027-2032) & (US$ Million) Table 106. China AI Drug Repurposing Platform Market Size by Application (2021-2026) & (US$ Million) Table 107. China AI Drug Repurposing Platform Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia AI Drug Repurposing Platform Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia AI Drug Repurposing Platform Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia AI Drug Repurposing Platform Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia AI Drug Repurposing Platform Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia AI Drug Repurposing Platform Market Size by Country (2021-2026) Table 114. Asia AI Drug Repurposing Platform Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. AI Drug Repurposing Platform Product Image Figure 2. Global AI Drug Repurposing Platform Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI Drug Repurposing Platform Market Share by Type: 2025 VS 2032 Figure 4. Target and Mechanism Mining Image Figure 5. Drug–Disease Matching Image Figure 6. Indication Expansion Image Figure 7. Combination Therapy Prediction Image Figure 8. Evidence Ranking and Validation Image Figure 9. Safety and Translational Assessment Image Figure 10. Global AI Drug Repurposing Platform Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global AI Drug Repurposing Platform Market Share by Application: 2025 VS 2032 Figure 12. Rare Disease Repurposing Image Figure 13. Oncology Indication Expansion Image Figure 14. Infectious Disease Response Image Figure 15. CNS and Neurology Research Image Figure 16. Immunology and Inflammation Research Image Figure 17. Asset Rescue and Pipeline Optimization Image Figure 18. Global AI Drug Repurposing Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 20. Global AI Drug Repurposing Platform Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global AI Drug Repurposing Platform Market Share by Players in 2025 Figure 23. Global Top 5 and 10 AI Drug Repurposing Platform Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global AI Drug Repurposing Platform Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global AI Drug Repurposing Platform Revenue Market Share by Type (2021-2032) Figure 27. Global AI Drug Repurposing Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global AI Drug Repurposing Platform Revenue Market Share by Application (2021-2032) Figure 29. North America AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 30. North America AI Drug Repurposing Platform Market Share by Type (2021-2032) Figure 31. North America AI Drug Repurposing Platform Market Share by Application (2021-2032) Figure 32. North America AI Drug Repurposing Platform Market Share by Country (2021-2032) Figure 33. United States AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 34. Canada AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 35. Mexico AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 36. Europe AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 37. Europe AI Drug Repurposing Platform Market Share by Type (2021-2032) Figure 38. Europe AI Drug Repurposing Platform Market Share by Application (2021-2032) Figure 39. Europe AI Drug Repurposing Platform Market Share by Country (2021-2032) Figure 40. Germany AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 41. France AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 42. U.K. AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 43. Italy AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 44. Russia AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 46. China AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 47. China AI Drug Repurposing Platform Market Share by Type (2021-2032) Figure 48. China AI Drug Repurposing Platform Market Share by Application (2021-2032) Figure 49. Asia AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 50. Asia AI Drug Repurposing Platform Market Share by Type (2021-2032) Figure 51. Asia AI Drug Repurposing Platform Market Share by Application (2021-2032) Figure 52. Asia AI Drug Repurposing Platform Market Share by Country (2021-2032) Figure 53. Japan AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 54. South Korea AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 57. India AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 58. Australia AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa AI Drug Repurposing Platform Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa AI Drug Repurposing Platform Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa AI Drug Repurposing Platform Market Share by Country (2021-2032) Figure 63. Brazil AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 64. South Africa AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 66. Turkey AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 67. Argentina AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 68. UAE AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 69. Egypt AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 70. Chile AI Drug Repurposing Platform Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Target and Mechanism Mining
  • Drug–Disease Matching
  • Indication Expansion
  • Combination Therapy Prediction
  • Evidence Ranking and Validation
  • Safety and Translational Assessment
Applications
  • Rare Disease Repurposing
  • Oncology Indication Expansion
  • Infectious Disease Response
  • CNS and Neurology Research
  • Immunology and Inflammation Research
  • Asset Rescue and Pipeline Optimization
Companies covered
  • Recursion
  • Lantern Pharma
  • SOM Biotech
  • Standigm
  • Pharos iBio
  • Aitia
  • Causaly
  • BenevolentAI
  • Healx
  • Insilico Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI Drug Repurposing Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Target and Mechanism Mining
  5. 1.2.3 Drug–Disease Matching
  6. 1.2.4 Indication Expansion
  7. 1.2.5 Combination Therapy Prediction
  8. 1.2.6 Evidence Ranking and Validation
  9. 1.2.7 Safety and Translational Assessment
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global AI Drug Repurposing Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Rare Disease Repurposing
  13. 1.3.3 Oncology Indication Expansion
  14. 1.3.4 Infectious Disease Response
  15. 1.3.5 CNS and Neurology Research
  16. 1.3.6 Immunology and Inflammation Research
  17. 1.3.7 Asset Rescue and Pipeline Optimization
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global AI Drug Repurposing Platform Growth Trends by Region
  20. 1.5.1 Global AI Drug Repurposing Platform Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 AI Drug Repurposing Platform Market Size by Region (2021-2026)
  22. 1.5.3 AI Drug Repurposing Platform Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global AI Drug Repurposing Platform Market Dynamics
  1. 2.1 AI Drug Repurposing Platform Industry Trends
  2. 2.2 AI Drug Repurposing Platform Industry Drivers
  3. 2.3 AI Drug Repurposing Platform Industry Opportunities and Challenges
  4. 2.4 AI Drug Repurposing Platform Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI Drug Repurposing Platform Revenue by Company (2021-2026)
  2. 3.2 Global AI Drug Repurposing Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI Drug Repurposing Platform Key Company Head office and Area Served
  4. 3.4 Global AI Drug Repurposing Platform Company, Product Type & Application
  5. 3.5 Global AI Drug Repurposing Platform Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI Drug Repurposing Platform Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI Drug Repurposing Platform Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI Drug Repurposing Platform Tier 1, Tier 2, and Tier 3
4 AI Drug Repurposing Platform Market by Type
  1. 4.1 Global AI Drug Repurposing Platform Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI Drug Repurposing Platform Market Size by Type (2021-2032)
  3. 4.3 Global AI Drug Repurposing Platform Market Size Share by Type (2021-2032)
5 AI Drug Repurposing Platform Market by Application
  1. 5.1 Global AI Drug Repurposing Platform Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Repurposing Platform Market Size by Application (2021-2032)
  3. 5.3 Global AI Drug Repurposing Platform Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Recursion
  2. 6.1.1 Recursion Company Information
  3. 6.1.2 Recursion Business Overview
  4. 6.1.3 Recursion AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Recursion AI Drug Repurposing Platform Product Portfolio
  6. 6.1.5 Recursion Recent Developments
  7. 6.2 Lantern Pharma
  8. 6.2.1 Lantern Pharma Company Information
  9. 6.2.2 Lantern Pharma Business Overview
  10. 6.2.3 Lantern Pharma AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Lantern Pharma AI Drug Repurposing Platform Product Portfolio
  12. 6.2.5 Lantern Pharma Recent Developments
  13. 6.3 SOM Biotech
  14. 6.3.1 SOM Biotech Company Information
  15. 6.3.2 SOM Biotech Business Overview
  16. 6.3.3 SOM Biotech AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 SOM Biotech AI Drug Repurposing Platform Product Portfolio
  18. 6.3.5 SOM Biotech Recent Developments
  19. 6.4 Standigm
  20. 6.4.1 Standigm Company Information
  21. 6.4.2 Standigm Business Overview
  22. 6.4.3 Standigm AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Standigm AI Drug Repurposing Platform Product Portfolio
  24. 6.4.5 Standigm Recent Developments
  25. 6.5 Pharos iBio
  26. 6.5.1 Pharos iBio Company Information
  27. 6.5.2 Pharos iBio Business Overview
  28. 6.5.3 Pharos iBio AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pharos iBio AI Drug Repurposing Platform Product Portfolio
  30. 6.5.5 Pharos iBio Recent Developments
  31. 6.6 Aitia
  32. 6.6.1 Aitia Company Information
  33. 6.6.2 Aitia Business Overview
  34. 6.6.3 Aitia AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Aitia AI Drug Repurposing Platform Product Portfolio
  36. 6.6.5 Aitia Recent Developments
  37. 6.7 Causaly
  38. 6.7.1 Causaly Company Information
  39. 6.7.2 Causaly Business Overview
  40. 6.7.3 Causaly AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Causaly AI Drug Repurposing Platform Product Portfolio
  42. 6.7.5 Causaly Recent Developments
  43. 6.8 BenevolentAI
  44. 6.8.1 BenevolentAI Company Information
  45. 6.8.2 BenevolentAI Business Overview
  46. 6.8.3 BenevolentAI AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BenevolentAI AI Drug Repurposing Platform Product Portfolio
  48. 6.8.5 BenevolentAI Recent Developments
  49. 6.9 Healx
  50. 6.9.1 Healx Company Information
  51. 6.9.2 Healx Business Overview
  52. 6.9.3 Healx AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Healx AI Drug Repurposing Platform Product Portfolio
  54. 6.9.5 Healx Recent Developments
  55. 6.10 Insilico Medicine
  56. 6.10.1 Insilico Medicine Company Information
  57. 6.10.2 Insilico Medicine Business Overview
  58. 6.10.3 Insilico Medicine AI Drug Repurposing Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Insilico Medicine AI Drug Repurposing Platform Product Portfolio
  60. 6.10.5 Insilico Medicine Recent Developments
7 North America
  1. 7.1 North America AI Drug Repurposing Platform Market Size (2021-2032)
  2. 7.2 North America AI Drug Repurposing Platform Market Size by Type
  3. 7.2.1 North America AI Drug Repurposing Platform Market Size by Type (2021-2026)
  4. 7.2.2 North America AI Drug Repurposing Platform Market Size by Type (2027-2032)
  5. 7.2.3 North America AI Drug Repurposing Platform Market Share by Type (2021-2032)
  6. 7.3 North America AI Drug Repurposing Platform Market Size by Application
  7. 7.3.1 North America AI Drug Repurposing Platform Market Size by Application (2021-2026)
  8. 7.3.2 North America AI Drug Repurposing Platform Market Size by Application (2027-2032)
  9. 7.3.3 North America AI Drug Repurposing Platform Market Share by Application (2021-2032)
  10. 7.4 North America AI Drug Repurposing Platform Market Size by Country
  11. 7.4.1 North America AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI Drug Repurposing Platform Market Size by Country (2021-2026)
  13. 7.4.3 North America AI Drug Repurposing Platform Market Size by Country (2027-2032)
  14. 7.4.4 North America AI Drug Repurposing Platform Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI Drug Repurposing Platform Market Size (2021-2032)
  2. 8.2 Europe AI Drug Repurposing Platform Market Size by Type
  3. 8.2.1 Europe AI Drug Repurposing Platform Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI Drug Repurposing Platform Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI Drug Repurposing Platform Market Share by Type (2021-2032)
  6. 8.3 Europe AI Drug Repurposing Platform Market Size by Application
  7. 8.3.1 Europe AI Drug Repurposing Platform Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI Drug Repurposing Platform Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI Drug Repurposing Platform Market Share by Application (2021-2032)
  10. 8.4 Europe AI Drug Repurposing Platform Market Size by Country
  11. 8.4.1 Europe AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI Drug Repurposing Platform Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI Drug Repurposing Platform Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI Drug Repurposing Platform Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI Drug Repurposing Platform Market Size (2021-2032)
  2. 9.2 China AI Drug Repurposing Platform Market Size by Type
  3. 9.2.1 China AI Drug Repurposing Platform Market Size by Type (2021-2026)
  4. 9.2.2 China AI Drug Repurposing Platform Market Size by Type (2027-2032)
  5. 9.2.3 China AI Drug Repurposing Platform Market Share by Type (2021-2032)
  6. 9.3 China AI Drug Repurposing Platform Market Size by Application
  7. 9.3.1 China AI Drug Repurposing Platform Market Size by Application (2021-2026)
  8. 9.3.2 China AI Drug Repurposing Platform Market Size by Application (2027-2032)
  9. 9.3.3 China AI Drug Repurposing Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI Drug Repurposing Platform Market Size (2021-2032)
  2. 10.2 Asia AI Drug Repurposing Platform Market Size by Type
  3. 10.2.1 Asia AI Drug Repurposing Platform Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI Drug Repurposing Platform Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI Drug Repurposing Platform Market Share by Type (2021-2032)
  6. 10.3 Asia AI Drug Repurposing Platform Market Size by Application
  7. 10.3.1 Asia AI Drug Repurposing Platform Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI Drug Repurposing Platform Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI Drug Repurposing Platform Market Share by Application (2021-2032)
  10. 10.4 Asia AI Drug Repurposing Platform Market Size by Country
  11. 10.4.1 Asia AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI Drug Repurposing Platform Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI Drug Repurposing Platform Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI Drug Repurposing Platform Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI Drug Repurposing Platform Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI Drug Repurposing Platform Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI Drug Repurposing Platform Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI Drug Repurposing Platform Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI Drug Repurposing Platform Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst